Adiponectin is associated with increased mortality in patients with already established cardiovascular disease: A systematic review and meta-analysis

Metabolism: Clinical and Experimental

Volumn 63, Issue 9, 2014, Pages 1157-1166

  Wu, Zhen Jie ^a   Cheng, Yun Jiu ^b   Gu, Wan Jie ^a   Aung, Lynn Htet Htet ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Adiponectin; Cardiovascular disease; Meta analysis; Mortality

Indexed keywords

ADIPONECTIN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; AGE; ANGINA PECTORIS; ARTICLE; BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; FOLLOW UP; GENDER; HEART MUSCLE ISCHEMIA; HUMAN; ISCHEMIC HEART DISEASE; META ANALYSIS; MORTALITY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PUBLISHING; SAMPLE SIZE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SUDDEN CARDIAC DEATH; SYSTEMATIC REVIEW; TRANSIENT ISCHEMIC ATTACK;

ADIPONECTIN; CARDIOVASCULAR DISEASE; META-ANALYSIS; MORTALITY;

ADIPONECTIN; CARDIOVASCULAR DISEASES; HUMANS; MORTALITY; PROSPECTIVE STUDIES; UP-REGULATION;

EID: 84906272324     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2014.05.001     Document Type: Article

References (57)

1. K. Maeda, K. Okubo, I. Shimomura, T. Funahashi, and Y. Matsuzawa et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1) Biochem Biophys Res Commun 221 1996 286 289
2. N. Ouchi, S. Kihara, Y. Arita, K. Maeda, and H. Kuriyama et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin Circulation 100 1999 2473 2476
3. N. Ouchi, S. Kihara, Y. Arita, M. Nishida, and A. Matsuyama et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages Circulation 103 2001 1057 1063
4. H. Kato, H. Kashiwagi, M. Shiraga, S. Tadokoro, and T. Kamae et al. Adiponectin acts as an endogenous antithrombotic factor Arterioscler Thromb Vasc Biol 26 2006 224 230
5. R. Shibata, K. Sato, D.R. Pimentel, Y. Takemura, and S. Kihara et al. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms Nat Med 11 2005 1096 1103
6. K. Fujita, N. Maeda, M. Sonoda, K. Ohashi, and T. Hibuse et al. Adiponectin protects against angiotensin II-induced cardiac fibrosis through activation of PPAR-alpha Arterioscler Thromb Vasc Biol 28 2008 863 870
7. M. Kumada, S. Kihara, S. Sumitsuji, T. Kawamoto, and S. Matsumoto et al. Association of hypoadiponectinemia with coronary artery disease in men Arterioscler Thromb Vasc Biol 23 2003 85 89
8. T. Pischon, C.J. Girman, G.S. Hotamisligil, N. Rifai, and F.B. Hu et al. Plasma adiponectin levels and risk of myocardial infarction in men JAMA 291 2004 1730 1737
9. J. Poehls, C.L. Wassel, T.B. Harris, P.J. Havel, and M.M. Swarbrick et al. Association of adiponectin with mortality in older adults: the Health, Aging, and Body Composition Study Diabetologia 52 2009 591 595
10. H. Zhang, X. Mo, Y. Hao, J. Huang, and X. Lu et al. Adiponectin levels and risk of coronary heart disease: a meta-analysis of prospective studies Am J Med Sci 345 2013 455 461
11. B.C. Zhang, W.J. Liu, W.L. Che, and Y.W. Xu Serum total adiponectin level and risk of cardiovascular disease in Han Chinese populations: a meta-analysis of 17 case-control studies Clin Endocrinol (Oxf) 77 2012 370 378
12. N. Sattar, G. Wannamethee, N. Sarwar, J. Tchernova, and L. Cherry et al. Adiponectin and coronary heart disease: a prospective study and meta-analysis Circulation 114 2006 623 629
13. D.A. Kanhai, M.E. Kranendonk, C.S. Uiterwaal, Y. van der Graaf, and L.J. Kappelle et al. Adiponectin and incident coronary heart disease and stroke. A systematic review and meta-analysis of prospective studies Obes Rev 14 2013 555 567
14. E. Sook Lee, S.S. Park, E. Kim, Y. Sook Yoon, and H.Y. Ahn et al. Association between adiponectin levels and coronary heart disease and mortality: a systematic review and meta-analysis Int J Epidemiol 42 2013 1029 1039
15. M. Arregui, B. Buijsse, A. Fritsche, R. di Giuseppe, and M.B. Schulze et al. Adiponectin and risk of stroke: prospective study and meta-analysis Stroke 45 2014 10 17
16. G. Hao, W. Li, R. Guo, J.G. Yang, and Y. Wang et al. Serum total adiponectin level and the risk of cardiovascular disease in general population: a meta-analysis of 17 prospective studies Atherosclerosis 228 2013 29 35
17. S.P. Efstathiou, D.I. Tsioulos, A.G. Tsiakou, Y.E. Gratsias, and A.V. Pefanis et al. Plasma adiponectin levels and five-year survival after first-ever ischemic stroke Stroke 36 2005 1915 1919
18. E. Cavusoglu, C. Ruwende, V. Chopra, S. Yanamadala, and C. Eng et al. Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain Eur Heart J 27 2006 2300 2309
19. S. Pilz, H. Mangge, B. Wellnitz, U. Seelhorst, and B.R. Winkelmann et al. Adiponectin and mortality in patients undergoing coronary angiography J Clin Endocrinol Metab 91 2006 4277 4286
20. K. Shioji, S. Moriwaki, Y. Takeuchi, T. Uegaito, and S. Mutsuo et al. Relationship of serum adiponectin level to adverse cardiovascular events in patients who undergo percutaneous coronary intervention Circ J 71 2007 675 680
21. S.G. Wannamethee, P.H. Whincup, L. Lennon, and N. Sattar Circulating adiponectin levels and mortality in elderly men with and without cardiovascular disease and heart failure Arch Intern Med 167 2007 1510 1517
22. G. Maiolino, M. Cesari, D. Sticchi, M. Zanchetta, and L. Pedon et al. Plasma adiponectin for prediction of cardiovascular events and mortality in high-risk patients J Clin Endocrinol Metab 93 2008 3333 3340
23. B. Dieplinger, M. Haltmayer, W. Poelz, and T. Mueller Value of adiponectin as predictor of 5-year all-cause mortality in patients with symptomatic peripheral arterial disease: results from the Linz Peripheral Arterial Disease (LIPAD) study Clin Chim Acta 408 2009 87 91
24. S.H. Lee, J.W. Ha, J.S. Kim, E.Y. Choi, and S. Park et al. Plasma adiponectin and resistin levels as predictors of mortality in patients with acute myocardial infarction: data from infarction prognosis study registry Coron Artery Dis 20 2009 33 39
25. S.S. Huang, P.H. Huang, Y.H. Chen, K.H. Chiang, and J.W. Chen et al. Association of adiponectin with future cardiovascular events in patients after acute myocardial infarction J Atheroscler Thromb 17 2010 295 303
26. H. Nagasawa, C. Yokota, K. Toyoda, A. Ito, and K. Minematsu High level of plasma adiponectin in acute stroke patients is associated with stroke mortality J Neurol Sci 304 2011 102 106
27. S.R. Wilson, M.S. Sabatine, S.D. Wiviott, K.K. Ray, and J.A. De Lemos et al. Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: observations from the Pravastatin Or atorVastatin Evaluation and Infection Trial-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Am Heart J 161 2011 1147 1155 [e1141]
28. A.L. Beatty, M.H. Zhang, I.A. Ku, B. Na, and N.B. Schiller et al. Adiponectin is associated with increased mortality and heart failure in patients with stable ischemic heart disease: data from the Heart and Soul Study Atherosclerosis 220 2012 587 592
29. J.R. Kizer, D. Benkeser, A.M. Arnold, K.J. Mukamal, and J.H. Ix et al. Associations of total and high-molecular-weight adiponectin with all-cause and cardiovascular mortality in older persons: the Cardiovascular Health Study Circulation 126 2012 2951 2961
30. Q. Li, Y. Lu, L. Sun, J. Yan, and X. Yan et al. Plasma adiponectin levels in relation to prognosis in patients with angiographic coronary artery disease Metabolism 61 2012 1803 1808
31. S. Lindberg, S.H. Pedersen, R. Mogelvang, M. Bjerre, and J. Frystyk et al. Usefulness of adiponectin as a predictor of all cause mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention Am J Cardiol 109 2012 492 496
32. S. Hascoet, M. Elbaz, V. Bongard, F. Bouisset, and C. Verdier et al. Adiponectin and long-term mortality in coronary artery disease participants and controls Arterioscler Thromb Vasc Biol 33 2013 e19 e29
33. J.M. Dekker, T. Funahashi, G. Nijpels, S. Pilz, and C.D. Stehouwer et al. Prognostic value of adiponectin for cardiovascular disease and mortality J Clin Endocrinol Metab 93 2008 1489 1496
34. P.E. Ronksley, S.E. Brien, B.J. Turner, K.J. Mukamal, and W.A. Ghali Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis BMJ 342 2011 d671
35. J.A. Hayden, D.A. van der Windt, J.L. Cartwright, P. Cote, and C. Bombardier Assessing bias in studies of prognostic factors Ann Intern Med 158 2013 280 286
36. J. Zhang, and K.F. Yu What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes JAMA 280 1998 1690 1691
37. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
38. J.P. Higgins, and S.G. Thompson Quantifying heterogeneity in a meta-analysis Stat Med 21 2002 1539 1558
39. C.B. Begg, and M. Mazumdar Operating characteristics of a rank correlation test for publication bias Biometrics 50 1994 1088 1101
40. M. Egger, G. Davey Smith, M. Schneider, and C. Minder Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634
41. J. Danesh, R. Collins, P. Appleby, and R. Peto Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies JAMA 279 1998 1477 1482
42. J. Danesh, R. Collins, and R. Peto Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies Circulation 102 2000 1082 1085
43. H. Hemingway, M. Henriksson, R. Chen, J. Damant, and N. Fitzpatrick et al. The effectiveness and cost-effectiveness of biomarkers for the prioritisation of patients awaiting coronary revascularisation: a systematic review and decision model Health Technol Assess 14 2010 1 151 [iii-iv]
44. G. Urbonaviciene, J. Frystyk, A. Flyvbjerg, E.W. Henneberg, and J.S. Lindholt Association of serum adiponectin with risk for cardiovascular events in patients with peripheral arterial disease Atherosclerosis 210 2010 619 624
45. P.E. Scherer, S. Williams, M. Fogliano, G. Baldini, and H.F. Lodish A novel serum protein similar to C1q, produced exclusively in adipocytes J Biol Chem 270 1995 26746 26749
46. S. Pilz, R. Horejsi, R. Moller, G. Almer, and H. Scharnagl et al. Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin J Clin Endocrinol Metab 90 2005 4792 4796
47. M. Shimabukuro, N. Higa, T. Asahi, Y. Oshiro, and N. Takasu et al. Hypoadiponectinemia is closely linked to endothelial dysfunction in man J Clin Endocrinol Metab 88 2003 3236 3240
48. S. Pilz, W. Maerz, G. Weihrauch, K. Sargsyan, and G. Almer et al. Adiponectin serum concentrations in men with coronary artery disease: the LUdwigshafen RIsk and Cardiovascular Health (LURIC) study Clin Chim Acta 364 2006 251 255
49. D. Rothenbacher, H. Brenner, W. Marz, and W. Koenig Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers Eur Heart J 26 2005 1640 1646
50. C. Kistorp, J. Faber, S. Galatius, F. Gustafsson, and J. Frystyk et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure Circulation 112 2005 1756 1762
51. V. Menon, L. Li, X. Wang, T. Greene, and V. Balakrishnan et al. Adiponectin and mortality in patients with chronic kidney disease J Am Soc Nephrol 17 2006 2599 2606
52. P.E. Szmitko, H. Teoh, D.J. Stewart, and S. Verma Adiponectin and cardiovascular disease: state of the art? Am J Physiol Heart Circ Physiol 292 2007 H1655 H1663
53. R. Schnabel, C.M. Messow, E. Lubos, C. Espinola-Klein, and H.J. Rupprecht et al. Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study Eur Heart J 29 2008 649 657
54. H.V. Lin, J.Y. Kim, A. Pocai, L. Rossetti, and L. Shapiro et al. Adiponectin resistance exacerbates insulin resistance in insulin receptor transgenic/knockout mice Diabetes 56 2007 1969 1976
55. K.L. Mullen, J. Pritchard, I. Ritchie, L.A. Snook, and A. Chabowski et al. Adiponectin resistance precedes the accumulation of skeletal muscle lipids and insulin resistance in high-fat-fed rats Am J Physiol Regul Integr Comp Physiol 296 2009 R243 R251
56. A.M. Van Berendoncks, A. Garnier, P. Beckers, V.Y. Hoymans, and N. Possemiers et al. Functional adiponectin resistance at the level of the skeletal muscle in mild to moderate chronic heart failure Circ Heart Fail 3 2010 185 194
57. U.B. Pajvani, X. Du, T.P. Combs, A.H. Berg, and M.W. Rajala et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity J Biol Chem 278 2003 9073 9085